tiprankstipranks
Trending News
More News >
Krystal Biotech (KRYS)
NASDAQ:KRYS
US Market

Krystal Biotech (KRYS) Income Statement

Compare
637 Followers

Krystal Biotech Income Statement

Last quarter (Q4 2025), Krystal Biotech's total revenue was $107.11M, an increase of 17.52% from the same quarter last year. In Q4, Krystal Biotech's net income was $51.40M. See Krystal Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 389.13M$ 290.51M$ 50.70M$ 0.00$ 0.00
Gross Profit
$ 360.36M$ 270.45M$ 47.60M$ 0.00$ 0.00
Operating Expenses
$ 199.06M$ 204.76M$ 157.33M$ 145.20M$ 68.28M
Depreciation and Amortization
$ 6.55M$ 6.71M$ 5.91M$ 3.38M$ 1.85M
EBITDA
$ 167.85M$ 109.91M$ -91.32M$ -116.81M$ -66.23M
Operating Income
$ 161.29M$ 65.69M$ -109.73M$ -145.20M$ -68.28M
Other Income/Expenses
$ 28.18M$ 29.66M$ 122.62M$ 5.22M$ -1.29M
Pretax Income
$ 189.47M$ 95.36M$ 12.90M$ -139.97M$ -69.57M
Net Income
$ 204.83M$ 89.16M$ 10.93M$ -139.97M$ -69.57M
Per Share Metrics
Basic EPS
$ 7.08$ 3.12$ 0.40$ -5.49$ -3.13
Diluted EPS
$ 6.84$ 3.00$ 0.39$ -5.49$ -3.13
Weighted Average Shares Outstanding
28.94M 28.59M 27.15M 25.49M 22.20M
Weighted Average Shares Outstanding (Diluted)
29.95M 29.74M 27.75M 25.49M 22.20M
Currency in USD

Krystal Biotech Earnings and Revenue History